Helse ·
Wearables, Sunscreen, and Pharma’s New Moves
Kilder
- STAT: Dexcom RCT suggests CGM benefits for broad diabetes population
- STAT: STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic
- Raps: Recon: GSK to buy Nuvalent for $10.6B; Pentagon labels WuXi AppTec as linked to Chinese military - RAPS.org
- STAT: Gilead and Merck’s latest trial success and flop - statnews.com
- STAT: FDA OKs first new sunscreen ingredient in more than 25 years
- AP: FDA OKs first new sunscreen ingredient in more than 25 years - AP News
- Pinalcentral: FDA OKs first new sunscreen ingredient in more than 25 years - PinalCentral.com
- Bozemandailychronicle: FDA OKs first new sunscreen ingredient in more than 25 years - Bozeman Daily Chronicle
- STAT: STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leaders
- STAT: Trump’s health care affordability czar takes aim at hospitals - statnews.com
- Raps: Recon: GSK to buy Nuvalent for $10.6B; Pentagon labels WuXi AppTec as linked to Chinese military - RAPS.org
- STAT: STAT+: What’s changed since the last major Ebola outbreak
- STAT: A leader of the 2014 U.S. Ebola response compares then to now - statnews.com
- STAT: STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
- Bostonglobe: GSK to buy Cambridge-based Nuvalent, maker of targeted cancer drugs, for $10.6 billion - The Boston Globe
- Raps: Recon: GSK to buy Nuvalent for $10.6B; Pentagon labels WuXi AppTec as linked to Chinese military - RAPS.org
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.